Archives

Webinar
The Changing Landscape of Real-World Evidence and its Impact on Clinical Research
Recorded on Thursday, June 21, 2018 | TriNetX

Researchers are encumbered with a plethora of disparate data and analytic tools. These assets pose several challenges which need to be overcome to ensure they satisfy their intended purpose. 

Watch this webinar to learn how real-time, self-service access to longitudinal patient data is changing the way researchers evaluate treatment effectiveness, safety, protocol design, and more. Register now.

Whitepaper
Getting to First-in-Human Clinical Trials: A Make-or-Break Milestone for Small Biopharmas
Patheon, part of Thermo Fisher Scientific

“Faster and better” has become the mantra for biopharmaceutical companies as they face intense pressure to get therapies to market faster. Quickly proving efficacy in first-in-human (FIH) trials is a make-or-break milestone for these cash-strapped companies whose hopes hinge upon one or two molecules. Read how CDMOs are responding to this pressure. 

Webinar
Best Practices to Meet Financial Objectives When Selecting an Investigator Payments Partner
Recorded on May 16, 2018 | Bioclinica

Watch this webinar and discover what best practices sponsors and CROs should follow when evaluating a current or future investigator payments partner. Register here.

Webinar
New Directive to Revolutionize HTA in Europe: How Will It Affect You?
Evidera

The new EU HTA Directive requires consistent comparative clinical efficacy assessment of EMA assessed treatments. Understand the history of the Directive, what is included, the proposed structure and timing, potential implications for industry and stakeholders, and how to prepare.  Register now.

Research
Rheumatology Adherence Data: Real-Time Stats on Medisafe that Pharma Should Know
Medisafe

Download this infographic for comparative data and valuable insider insights on rheumatology drug adherence that pharma companies should consider for their products and marketing strategies.

Video
OptiForm® Solution Suite
Catalent

Watch a video to learn how to incorporate everything you need to progress you drug candidate from late stage discovery to phase I into one comprehensive offering which can quickly help achieve your milestone

Paid Marketplace
Case Study | Improved Bioavailability Of Trio Medicines TML-2 In 12 Weeks
Catalent

Read a case study on how to utilize a parallel screening approach to selecting a most suitable formulation technology for an early phase BCS Class II compound.  The molecule was advanced to animal study with enhanced bioavailability in 12 weeks. 

Paid Marketplace
The Importance of Clinical Returns Planning
Catalent

Study sponsors often focus on upfront planning to ensure clinical sites are prepared to reach study milestones but ignore the logical challenges of managing their clinical returns. Learn how developing a forward-thinking plan to manage clinical returns can reduce study close out risk. 

Webinar
Is Your Clinical Supply Playbook Ready for Phase II and Beyond?
Catalent

Advancing beyond Phase I can be exciting – and eye opening – for clinical sponsors. By examining study factors known to be leading indicators of future clinical supply challenges, sponsors can take a proactive approach to clinical supplies, build realistic timelines and better forecast demand.

Research
Neurology Adherence Data: Real-Time Stats on Medisafe that Pharma Should Know
Medisafe

Download this Infographic for comparative data and valuable insider insights on neurology drug adherence that pharma companies should consider for their products and marketing strategies. 

Research
Gastrointestinal Adherence Data: Real-Time Stats on Medisafe that Pharma Should Know
Medisafe

Download this Infographic for comparative data and valuable insider insights on gastrointestinal drug adherence that pharma companies should consider for their products and marketing strategies. 

Whitepaper
[Whitepaper] Making the Business Case for RIM Transformation
Deloitte

Read Deloitte Consulting's whitepaper on the value of a holistic RIM capability, covering the potential cost savings and revenue gains from doing RIM right.

Webinar
CTTI’s Comprehensive Guide to Mobile Technologies in Clinical Trials
Recorded on October 11 2018 | Amazon Web Services

This action-oriented webinar will describe in detail the information investigators, sponsors, and service providers need to meet technical requirements, support collaborations, and understand each other’s needs and expectations—providing a pathway forward to make the use of mobile technologies in clinical trials a reality. Register now!

Paid Marketplace
Patient engagement through sponsored content on Inspire:
Inspire

A case of 29X increase in relative effectiveness

Whitepaper
A Researcher’s Goldmine: Quality, Motivated Participants, Fast
Inspire

Dave Taylor, director of market research at Inspire, describes case studies illustrating how life science companies can reduce the time it takes to conduct research by accessing a website that millions of patients flock to. Learn more.

Whitepaper
Delayed and Confusing IDMP Requirements Demand Two-Part Strategy
Veeva

Gartner research on preparing for IDMP


While the deadline for IDMP compliance is delayed, life sciences IT leaders supporting regulatory compliance can use this research to establish value-adding strategies for the short – and long – term. Read it now

Whitepaper
Industry Research Reveals Key Trends Accelerating the Shift to eTMF
Veeva

The largest survey of TMF owners reveals drivers and trends in improving inspection readiness and shortening trial time.  Read more.